Log in

Physical and psychiatric comorbidities among patients with severe mental illness as seen in Uganda

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

While psychiatric and physical comorbidities in severe mental illness (SMI) have been associated with increased mortality and poor clinical outcomes, problem has received little attention in low- and middle-income countries (LMICs). This study established the prevalence of psychiatric (schizophrenia, bipolar affective disorder, and recurrent major depressive disorder) and physical (HIV/AIDS, syphilis, hypertension and obesity) comorbidities and associated factors among 1201 out-patients with SMI (schizophrenia, depression and bipolar affective disorder) attending care at two hospitals in Uganda. Participants completed an assessment battery including structured, standardised and locally translated instruments. SMIs were established using the MINI International Neuropsychiatric Interview version 7.2. We used logistic regression to determine the association between physical and psychiatric comorbidities and potential risk factors. Bipolar affective disorder was the most prevalent (66.4%) psychiatric diagnoses followed by schizophrenia (26.6%) and recurrent major depressive disorder (7.0%). Prevalence of psychiatric comorbidity was 9.1%, while physical disorder comorbidity was 42.6%. Specific comorbid physical disorders were hypertension (27.1%), obesity (13.8%), HIV/AIDS (8.2%) and syphilis (4.8%). Potentially modifiable factors independently significantly associated with psychiatric and physical comorbidities were: use of alcohol for both syphilis and hypertension comorbidities; and use of a mood stabilisers and khat in comorbidity with obesity. Only psychiatric comorbidity was positively associated with the negative outcomes of suicidality and risky sexual behaviour. The healthcare models for psychiatric care in LMICs such as Uganda should be optimised to address the high burden of psychiatric and physical comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Availability of data and materials

All data and materials in this manuscript and additional files and figures attached are freely available with no restrictions.

References

  1. World Health Organization. Addressing comorbidity between mental disorders and major noncommunicable diseases. Background technical report to support implementation of the WHO European Mental Health Action Plan 2013–2020 and the WHO European Action Plan for the Prevention and Control of Noncommunicable Diseases 2016–2025. UN City, Marmorvej 51DK-2100 Copenhagen Ø, Denmark: WHO Regional Office for Europe 2017

  2. Richter D, Wall A, Bruen A, Whittington R (2019) Is the global prevalence rate of adult mental illness increasing? Systematic review and meta-analysis. Acta Psychiatr Scand 140(5):393–407

    Article  CAS  PubMed  Google Scholar 

  3. Häfner H (1985) Are mental disorders increasing over time? Psychopathology 18(2–3):66–81

    Article  PubMed  Google Scholar 

  4. Tkacz J, Brady BL (2021) Increasing rate of diagnosed childhood mental illness in the United States: incidence, prevalence and costs. Public Health in Practice 2:100204

    Article  PubMed  PubMed Central  Google Scholar 

  5. Twenge JM, Cooper AB, Joiner TE, Duffy ME, Binau SG (2019) Age, period, and cohort trends in mood disorder indicators and suicide-related outcomes in a nationally representative dataset, 2005–2017. J Abnorm Psychol 128(3):185–199

    Article  PubMed  Google Scholar 

  6. Crump C, Winkleby MA, Sundquist K, Sundquist J (2013) Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 170(3):324–333

    Article  PubMed  Google Scholar 

  7. Henderson M, Hotopf M, Shah I, Hayes RD, Kuh D (2011) Psychiatric disorder in early adulthood and risk of premature mortality in the 1946 British Birth Cohort. BMC Psychiatry 11(1):37

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lawrence D, Hancock KJ, Kisely S (2013) The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 346:f2539

    Article  PubMed  PubMed Central  Google Scholar 

  9. Laursen TM, Munk-Olsen T, Vestergaard M (2012) Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 25(2):83–88

    Article  PubMed  Google Scholar 

  10. Smith DJ, Langan J, McLean G, Guthrie B, Mercer SW (2013) Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open. https://doi.org/10.1136/bmjopen-2013-002808

    Article  PubMed  PubMed Central  Google Scholar 

  11. Scheen AJ, De Hert MA (2007) Abnormal glucose metabolism in patients treated with antipsychotics. Diabetes Metab 33(3):169–175

    Article  CAS  PubMed  Google Scholar 

  12. Samsom JN, Wong AHC (2015) Schizophrenia and depression co-morbidity: what we have learned from animal models. Front Psychiatry 6:13

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zhou C, Kong D, Zhu X, Wu W, Xue R, Li G et al (2020) Rethinking schizophrenia and depression comorbidity as one psychiatric disorder entity: evidence from mouse model. Front Neurosci 14:115

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tsai J, Rosenheck RA (2013) Psychiatric comorbidity among adults with schizophrenia: a latent class analysis. Psychiatry Res 210(1):16–20

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zolezzi M, Abdulrhim S, Isleem N, Zahrah F, Eltorki Y (2017) Medical comorbidities in patients with serious mental illness: a retrospective study of mental health patients attending an outpatient clinic in Qatar. Neuropsychiatr Dis Treat 13:2411–2418

    Article  PubMed  PubMed Central  Google Scholar 

  16. Patel V, Chatterji S (2015) Integrating mental health in care for noncommunicable diseases: an imperative for person-centered care. Health Affairs (Project Hope) 34(9):1498–1505

    Article  PubMed  Google Scholar 

  17. Zulman DM, Asch SM, Martins SB, Kerr EA, Hoffman BB, Goldstein MK (2014) Quality of care for patients with multiple chronic conditions: the role of comorbidity interrelatedness. J Gen Intern Med 29(3):529–537

    Article  PubMed  Google Scholar 

  18. Higashi T, Wenger NS, Adams JL, Fung C, Roland M, McGlynn EA et al (2007) Relationship between number of medical conditions and quality of care. N Engl J Med 356(24):2496–2504

    Article  CAS  PubMed  Google Scholar 

  19. Krein SL, Bingham CR, McCarthy JF, Mitchinson A, Payes J, Valenstein M (2006) Diabetes treatment among VA patients with comorbid serious mental illness. Psychiatr Serv (Washington, DC) 57(7):1016–1021

    Article  Google Scholar 

  20. Kwarisiima D, Atukunda M, Owaraganise A, Chamie G, Clark T, Kabami J et al (2019) Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study. BMC Public Health 19(1):511

    Article  PubMed  PubMed Central  Google Scholar 

  21. Centers for Medicare and Medicaid Services. Chronic Conditions Among Medicare Beneficiaries, Chartbook, 2012 Edition. Baltimore2012.

  22. Gladstone M, Lancaster GA, Umar E, Nyirenda M, Kayira E, van den Broek NR et al (2010) The Malawi Developmental Assessment Tool (MDAT): the creation, validation, and reliability of a tool to assess child development in rural African settings. PLoS Med 7(5):e1000273

    Article  PubMed  PubMed Central  Google Scholar 

  23. McCoy DC, Black MM, Daelmans B, Dua T (2016) Measuring development in children from birth to age 3 at population level 2016.

  24. World Health Organization (2013) Meeting report: autism spectrum disorders and other developmental disorders: from raising awareness to building capacity: World Health Organization, Geneva, Switzerland 16–18 September 2013. World Health Organization.

  25. Ajmera M, Wilkins TL, Findley PA, Sambamoorthi U (2012) Multimorbidity, mental illness, and quality of care: preventable hospitalizations among medicare beneficiaries. Int J Family Med 2012:823294

    Article  PubMed  PubMed Central  Google Scholar 

  26. Bank W (2021) Population Growth for Uganda [SPPOPGROWUGA]. Federal Reserve Bank of St. Louis: World Bank.

  27. Wakabi W (2006) Population growth continues to drive up poverty in Uganda. Lancet 367(9510):558

    Article  PubMed  Google Scholar 

  28. Gurdasani D, Carstensen T, Fatumo S, Chen G, Franklin CS, Prado-Martinez J et al (2019) Uganda genome resource enables insights into population history and genomic discovery in Africa. Cell 179(4):984-1002.e36

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Kinyanda E, Hjelmeland H, Musisi S (2005) Negative life events associated with deliberate self-harm in an African population in Uganda. Crisis 26(1):4–11

    Article  CAS  PubMed  Google Scholar 

  30. Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V (2011) Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. BMC Psychiatry 11:205

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kinyanda E, Waswa L, Baisley K, Maher D (2011) Prevalence of severe mental distress and its correlates in a population-based study in rural south-west Uganda. BMC Psychiatry 8(11):97

    Article  Google Scholar 

  32. Margolis PJ, Weintraub S (1977) The revised 56-item CRPBI as a research instrument: reliability and factor structure. J Clin Psychol 33:472–476

    Article  Google Scholar 

  33. Kinyanda E, Woodburn P, Tugumisirize J, Kagugube J, Ndyanabangi S, Patel V (2011) Poverty, life events and the risk for depression in Uganda. Soc Psychiatry Psychiatr Epidemiol 46(1):35–44

    Article  PubMed  Google Scholar 

  34. Kinyanda E, Weiss HA, Mungherera M, Onyango-Mangen P, Ngabirano E, Kajungu R et al (2012) Psychiatric disorders and psychosocial correlates of high HIV risk sexual behaviour in war-affected Eastern Uganda. AIDS Care 24(11):1323–1332

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA (1990) Psychometric characteristics of the multidimensional scale of perceived social support. J Pers Assess 55(3–4):610–617

    Article  CAS  PubMed  Google Scholar 

  36. King M, Dinos S, Shaw J, Watson R, Stevens S, Passetti F et al (2007) The Stigma Scale: development of a standardised measure of the stigma of mental illness. Br J Psychiatry 190:248–254

    Article  PubMed  Google Scholar 

  37. Fink B (1998) Childhood trauma questionnaire: a retrospective self-report manual. The Psychological Corporation, San Antonia TX

    Google Scholar 

  38. Kinyanda E, Nakasujja N, Levin J, Birabwa H, Mpango R, Grosskurth H et al (2017) Major depressive disorder and suicidality in early HIV infection and its association with risk factors and negative outcomes as seen in semi-urban and rural Uganda. J Affect Disord 212:117–127

    Article  PubMed  Google Scholar 

  39. Kerkhof AJFM, Bernasco W, Bille-Brahe U, Platt S, Schmidtke A (1989) A WHO/EURO Multicentre study on parasuicide. In: Schiødt H, Aagaard B (eds) European Parasuicide study interview schedule EPSIS I version 6.2. The Netherlands: Department and Clinical and Health Psychology, University of Leiden

  40. Ewing JA (1984) Detecting alcoholism. The CAGE questionnaire. JAMA 252(14):1905–1907

    Article  CAS  PubMed  Google Scholar 

  41. Kaleebu P, Kitandwe PK, Lutalo T, Kigozi A, Watera C, Nanteza MB, Hughes P, Musinguzi J, Opio A, Downing R, Mbidde EK (2018) Evaluation of HIV-1 rapid tests and identification of alternative testing algorithms for use in Uganda. BMC Infect Dis. https://doi.org/10.1186/s12879-018-3001-4

    Article  PubMed  PubMed Central  Google Scholar 

  42. Shah D, Marfatia YS (2019) Serological tests for syphilis. Indian J Sex Transm Dis AIDS 40(2):186–191

    Article  PubMed  PubMed Central  Google Scholar 

  43. Daré LO, Bruand P-E, Gérard D, Marin B, Lameyre V, Boumédiène F et al (2019) Co-morbidities of mental disorders and chronic physical diseases in develo** and emerging countries: a meta-analysis. BMC Public Health 19(1):304

    Article  PubMed  PubMed Central  Google Scholar 

  44. Rukundo ZG, Nakasujja N, Musisi S (2013) Psychiatric morbidity among physically ill patients in a Ugandan Regional Referral Hospital. Afr Health Sci 13(1):82–86

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Doherty AM, Gaughran F (2014) The interface of physical and mental health. Soc Psychiatry Psychiatr Epidemiol 49(5):673–682

    Article  PubMed  Google Scholar 

  46. Nadler S, Baker G, Morris K (1997) Descartes’s dualism. Philos Books 38(3):157–169

    Article  Google Scholar 

  47. Ulzen TP, Hamilton H (1998) The nature and characteristics of psychiatric comorbidity in incarcerated adolescents. Can J Psychiatry 43(1):57–63

    Article  CAS  PubMed  Google Scholar 

  48. Alfredo C, Leiva-Bianchi M, Serrano C, Teuber S, Cáceres C, Vitriol V (2018) Factors associated with psychiatric comorbidity in depression patients in primary health care in Chile. Depress Res Treat 2018:1–9

    Article  Google Scholar 

  49. Buckley PF, Miller BJ, Lehrer DS, Castle DJ (2009) Psychiatric comorbidities and schizophrenia. Schizophr Bull 35(2):383–402

    Article  PubMed  Google Scholar 

  50. AmericanPsychiatricAssociation (2000) ‘Diagnostic and statistical manual of mental disorders—text revision’. IV-R, editor. Washington, DC: Author

  51. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders. ed t, editor. Arlington, VA: American Psychiatric Publishing

  52. Laursen TM, Agerbo E, Pedersen CB (2009) Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index. J Clin Psychiatry 70(10):1432–1438

    Article  PubMed  Google Scholar 

  53. Oreški I, Jakovljević M, Aukst-Margetić B, Orlić ZC, Vuksan-Ćusa B (2012) Comorbidity and multimorbidity in patients with schizophrenia and bipolar disorder: similarities and differencies. Psychiatr Danub 24(1):80–85

    PubMed  Google Scholar 

  54. UNAIDS. Uganda Country Report. 2018.

  55. Maling S, Todd J, Van der Paal L, Grosskurth H, Kinyanda E (2011) HIV-1 seroprevalence and risk factors for HIV infection among first-time psychiatric admissions in Uganda. AIDS Care 23(2):171–178

    Article  PubMed  Google Scholar 

  56. Lundberg P, Nakasujja N, Musisi S, Thorson AE, Cantor-Graae E, Allebeck P (2013) HIV prevalence in persons with severe mental illness in Uganda: a cross-sectional hospital-based study. Int J Ment Heal Syst 7:20

    Article  Google Scholar 

  57. Uganda MoHo (2014) 2013 Uganda HIV and AIDS country progress report

  58. International UMoHaI (2012) 2011 Uganda AIDS indicator survey: key findings. MOHand ICF Internationa, Calverton, Maryland, USA

    Google Scholar 

  59. Bank W (2016) Uganda/ World Bank Development Indicators: Uganda—prevalence of syphilis (% of women attending antenatal care)

  60. Lundberg P, Nakasujja N, Musisi S, Thorson AE, Cantor-Graae E, Allebeck P (2015) Sexual risk behavior, sexual violence, and HIV in persons with severe mental illness in Uganda: hospital-based cross-sectional study and national comparison data. Am J Public Health 105(6):1142–1148

    Article  PubMed  PubMed Central  Google Scholar 

  61. Guwatudde D, Mutungi G, Wesonga R, Kajjura R, Kasule H, Muwonge J et al (2015) The epidemiology of hypertension in Uganda: findings from the national non-communicable diseases risk factor survey. PLoS ONE 10(9):e0138991

    Article  PubMed  PubMed Central  Google Scholar 

  62. Woodhead C, Ashworth M, Schofield P, Henderson M (2014) Patterns of physical co-/multi-morbidity among patients with serious mental illness: a London borough-based cross-sectional study. BMC Fam Pract 15:117

    Article  PubMed  PubMed Central  Google Scholar 

  63. Reilly S, Olier I, Planner C, Doran T, Reeves D, Ashcroft DM et al (2015) Inequalities in physical comorbidity: a longitudinal comparative cohort study of people with severe mental illness in the UK. BMJ Open 5(12):e009010

    Article  PubMed  PubMed Central  Google Scholar 

  64. England PH (2017) Hypertension prevalence estimates in England, 2017. Public Health England, London

    Google Scholar 

  65. Kirunda BE, Fadnes LT, Wamani H, Van den Broeck J, Tylleskär T (2015) Population-based survey of overweight and obesity and the associated factors in peri-urban and rural Eastern Uganda. BMC Public Health 15(1):1168

    Article  PubMed  PubMed Central  Google Scholar 

  66. Correll CU, Druss BG, Lombardo I, O’Gorman C, Harnett JP, Sanders KN et al (2010) Findings of a US national cardiometabolic screening program among 10,084 psychiatric outpatients. Psychiatr Serv (Washington, DC). 61(9):892–898

    Article  Google Scholar 

  67. Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief 82:1–8

    Google Scholar 

  68. Integrating the response to mental disorders and other chronic diseases in health care systems [press release]. Geneva: World Health Organization2014

  69. Academy of Medical Sciences (2018) Multimorbidity: a priority for global health research. United Kingdom

  70. Oni T, Unwin N (2015) Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition. Int Health 7(6):390–399

    PubMed  PubMed Central  Google Scholar 

  71. Assembly UNG (2011) Prevention and control of non-communicable diseases. United Nations, New York

    Google Scholar 

  72. Kabudula CW, Houle B, Collinson MA, Kahn K, Gómez-Olivé FX, Tollman S et al (2017) Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis. Lancet Glob Health 5(9):e924–e935

    Article  PubMed  PubMed Central  Google Scholar 

  73. Panagioti M, Stokes J, Esmail A, Coventry P, Cheraghi-Sohi S, Alam R et al (2015) Multimorbidity and patient safety incidents in primary care: a systematic review and meta-analysis. PLoS ONE 10(8):e0135947

    Article  PubMed  PubMed Central  Google Scholar 

  74. van Dooren FE, Nefs G, Schram MT, Verhey FR, Denollet J, Pouwer F (2013) Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS ONE 8(3):e57058

    Article  PubMed  PubMed Central  Google Scholar 

  75. Marc DEH, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I et al (2011) Physical illness in patients with severe mental disorders I Prevalence, impact of medications and disparities in health care. World Psychiatry 10(1):52–77

    Article  Google Scholar 

  76. Correll CU, Detraux J, De Lepeleire J, De Hert M (2015) Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 14(2):119–136

    Article  PubMed  PubMed Central  Google Scholar 

  77. Barnes PJ (2015) Mechanisms of development of multimorbidity in the elderly. Eur Respir J 45(3):790

    Article  CAS  PubMed  Google Scholar 

  78. Khansari N, Shakiba Y, Mahmoudi M (2009) Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 3(1):73–80

    Article  CAS  PubMed  Google Scholar 

  79. Pawelec G, Goldeck D, Derhovanessian E (2014) Inflammation, ageing and chronic disease. Curr Opin Immunol 29:23–28

    Article  CAS  PubMed  Google Scholar 

  80. Stepanova M, Rodriguez E, Birerdinc A, Baranova A (2015) Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity. Oncotarget 6(3):1414–1421

    Article  PubMed  PubMed Central  Google Scholar 

  81. Cerdá M, Sagdeo A, Johnson J, Galea S (2010) Genetic and environmental influences on psychiatric comorbidity: a systematic review. J Affect Disord 126(1–2):14–38

    Article  PubMed  Google Scholar 

  82. Bjekić M, Vla**ac H, Marinković J (2000) Behavioural and social characteristics of subjects with repeated sexually transmitted diseases. Acta Derm Venereol 80(1):44–47

    PubMed  Google Scholar 

  83. Zenilman JM, Hook EWI, Shepherd M, Smith P, Rompalo AM, Celentano DD (1994) Alcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infection. Sex Transm Dis 21(4):220–225

    Article  CAS  PubMed  Google Scholar 

  84. Briasoulis A, Agarwal V, Messerli FH (2012) Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens (Greenwich) 14(11):792–798

    Article  PubMed  Google Scholar 

  85. Rehm J, Roerecke M (2017) Cardiovascular effects of alcohol consumption. Trends Cardiovasc Med 27(8):534–538

    Article  CAS  PubMed  Google Scholar 

  86. Alshagga MA, Alshawsh MA, Seyedan A, Alsalahi A, Pan Y, Mohankumar SK et al (2016) Khat (Catha edulis) and obesity: a sco** review of animal and human studies. Ann Nutr Metab 69(3–4):200–211

    Article  CAS  PubMed  Google Scholar 

  87. Qin P, Hawton K, Mortensen PB, Webb R (2014) Combined effects of physical illness and comorbid psychiatric disorder on risk of suicide in a national population study. Br J Psychiatry 204(6):430–435

    Article  PubMed  Google Scholar 

  88. Ramrakha S, Caspi A, Dickson N, Moffitt TE, Paul C (2000) Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. BMJ (Clinical research ed) 321(7256):263–266

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank the managers of the two study sites (Butabika National Psychiatric Referral Hospital and Masaka Regional Referral Hospital) for permitting the study to be conducted at their out-patient departments. The authors extend appreciation to the Medical Research Council, Uganda (MRC, Uganda) for funding and facilitating the study. Special gratitude is extended to the staff working at the two out-patient departments where the study was conducted. Appreciation is extended to the diligent work of research assistants. Gratitude is extended to the participants for their time and trust.

Funding

This study was funded by Medical Research Council (MRC core funding to the Mental Health project of Medical Research Council (MRC)/Uganda Virus Research Institute (UVRI) and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Unit under the headship of Professor Eugene Kinyanda to undertake the ‘HIV clinical trials preparedness studies among patients with Severe Mental ILlnEss in HIV endemic Uganda (SMILE Study)’.

Author information

Authors and Affiliations

Authors

Contributions

Dr. Richard Stephen Mpango (RSM), Mr. Wilber Ssembajjwe (WS), Dr. Godfrey Zari Rukundo (GZR), Dr. Carol Birungi (CB), Professor Kenneth D. Gadow (KDG), Dr. Allan Kalungi (AK), Professor Vikram Patel (VP), Professor Moffat Nyirenda (MN) and Professor Eugene Kinyanda (EK) have made substantial contributions to conception, design, acquisition of data, drafting the manuscript, revising it critically and gave the final approval of this version to be published. WS did the analysis and interpretation of data. Each author participated sufficiently in this work and takes public responsibility for appropriate portions of the content.

Corresponding author

Correspondence to Richard Stephen Mpango.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethics approval and consent to participate

The study obtained ethical approvals from the Uganda Virus Research Institute’s Research and Ethics Committee (GC/127/19/10/612) and the Uganda National Council of Science and Technology (HS 2337). Participants were given information about the study by trained study Psychiatric Nurses/Psychiatric Clinical Officers and informed consent and assent sought before enrolment into the study. Participants found to have a SMI were provided healthcare and supported at the out-patient departments (OPDs) of their respective hospitals. Informed consent and assent were obtained from all the individual participants included in the study.

Consent to publish

Not applicable.

Supplementary Information

Below is the link to the electronic supplementary material.

406_2022_1478_MOESM1_ESM.docx

Table S4 Psychosocial and psychiatric illness factors associated with comorbid psychiatric and physical disorders at bivariate analysis (DOCX 15 KB)

406_2022_1478_MOESM2_ESM.docx

Table S5: Final multivariate model of socio-demographic, psychosocial and psychiatric illness factors associated with psychiatric and physical comorbidity (DOCX 17 KB)

Table S7: Measures and variables for the study (DOCX 65 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mpango, R.S., Ssembajjwe, W., Rukundo, G.Z. et al. Physical and psychiatric comorbidities among patients with severe mental illness as seen in Uganda. Eur Arch Psychiatry Clin Neurosci 273, 613–625 (2023). https://doi.org/10.1007/s00406-022-01478-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-022-01478-6

Keywords

Navigation